Valuation: Danaher Corporation

Market Cap 163B 887B 146B 135B 122B 228B 15,513B 232B 1,605B 644B 8,160B 613B 600B 25,735B P/E 2026 *
36.9x
P/E 2027 * 30.9x
Enterprise Value 184B 999B 165B 152B 137B 257B 17,467B 261B 1,807B 725B 9,188B 690B 676B 28,976B EV / Sales 2026 *
7x
EV / Sales 2027 * 6.35x
Free-Float
70.57%
Yield 2026 *
0.62%
Yield 2027 * 0.68%
1 day-1.12%
1 week+9.95%
1 month+10.98%
3 months+28.23%
6 months+42.42%
Current year-0.13%
1 week 43.99
Extreme 43.99
45.87
1 month 38
Extreme 38
45.87
Current year 28.02
Extreme 28.02
46
1 year 28.02
Extreme 28.02
46.06
3 years 28.02
Extreme 28.02
57.37
5 years 28.02
Extreme 28.02
66.27
10 years 8.86
Extreme 8.858775
66.27
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%+9.95% - - 163B
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-2.57%+3.30%+11.59%+44.40% 53.03B
-.--%+2.46%-11.97%-6.29% 53.31B
-3.47%+1.04%+19.48%+69.17% 49.3B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -1.90%-0.30%+1.35%+43.12% 98.16B
Weighted average by Cap. -1.95%+0.15%+4.00%+44.71%

Financials

2026 *2027 *
Net sales 26.26B 143B 23.52B 21.63B 19.6B 36.64B 2,494B 37.33B 258B 104B 1,312B 98.56B 96.46B 4,137B 28.28B 154B 25.33B 23.3B 21.11B 39.46B 2,685B 40.2B 278B 112B 1,413B 106B 104B 4,455B
Net income 4.4B 23.87B 3.94B 3.62B 3.28B 6.13B 417B 6.25B 43.19B 17.34B 220B 16.5B 16.15B 692B 5.22B 28.32B 4.67B 4.3B 3.89B 7.28B 495B 7.41B 51.23B 20.57B 260B 19.57B 19.16B 821B
Net Debt 20.58B 112B 18.43B 16.95B 15.36B 28.71B 1,954B 29.25B 202B 81.15B 1,028B 77.23B 75.59B 3,241B 16.09B 87.35B 14.41B 13.25B 12.01B 22.44B 1,527B 22.86B 158B 63.44B 803B 60.37B 59.08B 2,534B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
30/10/26 R$45.19 -1.12% 265
29/10/26 R$45.70 +2.35% 9
28/10/26 R$44.65 +0.40% 15,532
27/10/26 R$44.47 -0.65% 3,182
26/10/26 R$44.76 +8.91% 8,482
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
232.23USD
Average target price
259.90USD
Spread / Average Target
+11.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Danaher Corporation